期刊
ORTHOPAEDIC NURSING
卷 29, 期 3, 页码 176-180出版社
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/NOR.0b013e3181dcd2a2
关键词
-
An emerging problem for patients taking bisphosphonate (BSP) medications for osteoporosis or cancer therapies has been the occurrence of osteonecrosis of the jaws (ONJ), most often after dental surgical procedures. ONJ can be a persistent and discomforting condition that can also be refractory to various therapies. This article will overview the pathophysiology of ONJ, the proposed causal relationship between BSP use and ONJ, and the current guidelines for dental care of a patient who will be, or is taking, this class of medications. Included are suggested guidelines for the orthopaedic nurse who may interact with these patients. Alternate names for this malady are as follows: BSP-induced osteonecrosis of the jaws (BIONJ) BSP-related osteonecrosis of the jaws (BON, BRONJ)
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据